2018
Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer – A systematic review and meta-analysis
Vuong H, Ho A, Altibi A, Nakazawa T, Katoh R, Kondo T. Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer – A systematic review and meta-analysis. Lung Cancer 2018, 123: 76-82. PMID: 30089599, DOI: 10.1016/j.lungcan.2018.07.006.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerMET exonCell lung cancerAdvanced non-small cell lung cancerLung cancerGenetic eventsOdds ratioPulmonary sarcomatoid carcinomaMeta-analysisConfidence intervalsC-Met inhibitorsRandom-effects modelSarcomatoid carcinomaPrognostic featuresClinicopathological profileDismal survivalTargeted therapyClinicopathological implicationsGenomic alterationsAdvanced ageWeb of ScienceC-MetNon-smokersRare mutationsPatients
2016
The changing characteristics and molecular profiles of papillary thyroid carcinoma over time - a systematic review
Vuong H, Altibi A, Abdelhamid A, Ngoc P, Quan V, Tantawi M, Elfil M, Le Huy Vu T, Elgebaly A, Oishi N, Nakazawa T, Hirayama K, Katoh R, Huy N, Kondo T. The changing characteristics and molecular profiles of papillary thyroid carcinoma over time - a systematic review. Oncotarget 2016, 5: 10637-10649. PMID: 27793009, PMCID: PMC5354688, DOI: 10.18632/oncotarget.12885.Peer-Reviewed Original ResearchMeSH KeywordsAdultBiomarkers, TumorCarcinoma, PapillaryChi-Square DistributionFemaleGene RearrangementGenes, rasGenetic Predisposition to DiseaseHumansMaleMiddle AgedMutationPhenotypeProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-retRisk FactorsThyroid Cancer, PapillaryThyroid NeoplasmsTime FactorsTranscriptomeConceptsPapillary thyroid carcinomaMolecular profilingThyroid carcinomaClinicopathological featuresGenetic alterationsRisk factors of thyroid cancerPapillary thyroid carcinoma patientsSystematic reviewSurgical time periodStudent's t-testTumorigenesis of papillary thyroid carcinomaRET/PTC rearrangementsModification of patientsPearson chi-squareTeam of reviewersClinicopathological characteristicsPTC patientsBRAF mutationsThyroid cancerRAS mutationsScreened titlesRisk factorsInclusion criteriaElectronic databasesPotential articles